Key result
Creation of a pericardial window for malignant pericardial effusion resulted in no operative deaths, with 26% of patients surviving 1 or more years and 50% dying within 3 months.
Why the study?
Does the creation of a pericardial window provide safe management of malignant pericardial effusion in patients with malignancy?
Observational (n=66)
Does the creation of a pericardial window provide safe management of malignant pericardial effusion in patients with malignancy?
Answers are grounded in this paper and cite their sources.
Creation of a pericardial window is a safe procedure for managing malignant pericardial effusion, allowing for the continuation of primary malignancy therapy despite poor overall prognosis.
From January 1967 through November 1983, 66 patients with a previously established diagnosis of malignancy were treated for pericardial effusion by the creation of a pericardial window. The majority of the patients had malignancies of the breast or lung, or lymphoma. There were no deaths or major complications attributable to the operative procedures. The presence of malignant pericardial effusion is usually evidence of far-advanced disease and, therefore, the prognosis is poor. Seventeen patients (26%) were alive 1 or more years postoperatively and 33 patients (50%) died within 3 months of operation. Despite the grave prognosis, it is still our belief that malignant pericardial effusion should be treated aggressively by open surgical drainage so that continuation of therapy for the primary malignancy would be possible.
No takes yet. Share an insight, caveat, or question.
Reitknecht et al. (1985) conducted an observational in Malignant pericardial effusion (n=66). Creation of a pericardial window was evaluated on Survival at 1 or more years. Creation of a pericardial window for malignant pericardial effusion resulted in no operative deaths, with 26% of patients surviving 1 or more years and 50% dying within 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: